Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial

J. De Brandt (Diepenbeek, Belgium), W. Derave (Ghent, Belgium), F. Vandenabeele (Diepenbeek, Belgium), J. Aumann (Hasselt, Belgium), L. Blancquaert (Ghent, Belgium), I. Everaert (Ghent, Belgium), M. Spruit (Diepenbeek, Belgium)

Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Session: Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Session type: Oral Presentation
Number: 4748
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. De Brandt (Diepenbeek, Belgium), W. Derave (Ghent, Belgium), F. Vandenabeele (Diepenbeek, Belgium), J. Aumann (Hasselt, Belgium), L. Blancquaert (Ghent, Belgium), I. Everaert (Ghent, Belgium), M. Spruit (Diepenbeek, Belgium). Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial. 4748

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008


Randomised double blind placebo controlled trial of selenium supplementation in adult asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Dietary nitrate supplementation and exercise tolerance in chronic heart failure: A double-blind, randomized, placebo-controlled, crossover trial
Source: International Congress 2016 – Clinical exercise physiology in health and disease
Year: 2016

Efficacy of a synbiotic supplementation in the prevention of respiratory and intestinal diseases in children: A randomized, double-blind placebo controlled study
Source: Annual Congress 2010 - Childhood pneumonia: from prevention to complications
Year: 2010


A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study
Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021
Year: 2021



A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021
Year: 2021



Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


Substitution of vitamin D in patients with moderate to severe persistent asthma: A randomized, placebo-controlled pilot study
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012




Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010

RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Umeclidinium in patients with COPD: a randomised, placebo-controlled study
Source: Eur Respir J 2014; 43: 72-81
Year: 2004



The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Detrimental effects of β-blockers in COPD: a concern for nonselective β-blockers: a randomised, placebo controlled, cross-over study
Source: Eur Respir J 2003; 22: Suppl. 45, 49s
Year: 2003

Efficacy of a short course of oral prednisolone for acute preschool viral-wheeze: a double-blind randomised placebo-controlled trial with stratification for systemic eosinophil priming
Source: Eur Respir J 2003; 22: Suppl. 45, 388s
Year: 2003

Roflumilast in Asian patients with COPD: A randomised placebo-controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009

Vitamin E supplementation in the treatment of asthma: a randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 146s
Year: 2002